Genexine, Inc. (095700.KQ) KOE

Currency In KRW

AD

Valuation

Market Cap213.02B
Enterprise Value311.72B
P/E Ratio-3.49
PEG Ratio-0.62
Price/Sales Ratio22.51
Price/Book Ratio0.56
Enterprise/Revenue43.61
Enterprise/EBITDA299.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-6.46
Operating Margin-7.87
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.14

Income Statement

Revenue4.57B
Revenue/Share109.27
Gross Profit-4.28B
EBITDA-29.04B
Net Income-27.01B
Diluted EPS-594.1

Balance Sheet

Total Cash25.86B
Total Cash/Share568.52
Total Debt114.92B
Total Debt/Equity0.57
Current Ratio0.27
Book Value Per Share4,400.11

Price History

52-Week Change-53.05
52-Week High7,490
52-Week Low2,140
Moving Average 50 Days2,807.2
Moving Average 200 Days3,787.73

Statistics

Average Volume415,144
Shares Outstanding45.48M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor13:10
Last Split DateJanuary 11, 2023
AD